Viktoria K.
- Country
- Greece
- Department
- Department of Emergencey Medicine
Research Overview
Data & Insights
Has run more than one trial at 0 of 10 partner sites.
Specializations
Lung Cancer & Thoracic Oncology
The investigator concentrates on malignant diseases of the respiratory system, especially non‑small cell lung cancer, small cell lung cancer, and related metastatic conditions.
- Non‑small cell lung cancer
- Small cell lung cancer
- KRAS‑mutated NSCLC
- EGFR‑mutated NSCLC
- Lung cancer brain metastases
Research emphasizes targeted agents, immunotherapeutic strategies, and molecular profiling to improve outcomes.
Hematologic Malignancies
Work in this area includes studies on acute myeloid leukemia, chronic lymphocytic leukemia, and aggressive lymphomas such as diffuse large B‑cell lymphoma.
- Acute myeloid leukemia
- Chronic lymphocytic leukemia
- Diffuse large B‑cell lymphoma
- Multiple myeloma
- Myelofibrosis
Efforts focus on novel cytotoxic combinations, cellular therapies, and disease‑specific biomarkers.
Cardiovascular & Metabolic Disorders
The investigator addresses acute and chronic heart conditions, including acute myocardial infarction, atrial fibrillation, and heart failure with reduced ejection fraction, as well as metabolic risk factors such as type 2 diabetes and atherosclerotic cardiovascular disease.
- Acute myocardial infarction
- Atrial fibrillation
- Heart failure (HFrEF)
- Atherosclerotic cardiovascular disease
- Type 2 diabetes
Studies target prevention of major adverse cardiovascular events and integration of metabolic control.
Autoimmune & Systemic Inflammatory Diseases
Research encompasses systemic immune disorders such as systemic lupus erythematosus, rheumatoid arthritis, and vasculitic syndromes including antineutrophil cytoplasmic antibody‑associated vasculitis.
- Systemic lupus erythematosus
- Rheumatoid arthritis
- Vasculitis (AAV)
- Idiopathic inflammatory myopathies
- Sjogren’s syndrome
Focus is on disease‑modifying agents and biomarkers that reflect immune activity.
Infectious Diseases & Immunodeficiency
The investigator’s portfolio includes emerging and chronic infections, notably COVID‑19, chronic hepatitis B, and viral diseases such as human immunodeficiency virus, as well as severe bacterial and fungal sepsis.
- COVID‑19
- Chronic hepatitis B
- HIV infection
- Sepsis and severe bacterial infections
- Invasive fungal infections
Efforts aim to improve antiviral and antimicrobial strategies and to support immunocompromised patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.